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ABSTRACT 
Objective: This investigation includes characterization of phytochemicals from acetone extract of Helianthus annuus L. seeds responsible for α-
amylase and α-glucosidase inhibition revealed from in vitro and in silico approaches. 
Methods: Seed extract was qualitatively and quantitatively analysed for the presence of bioactive molecules. In vitro α-amylase and α-glucosidase 
inhibition assays and kinetics studies for α-glucosidase were done. Thin layer chromatography (TLC) autography of extract was done to screen 
potent inhibitors and characterized by high-resolution liquid chromatography-mass spectrometry (HR LC-MS). Characterized molecules were 
further used for in silico studies. 
Results: Qualitative investigation reveals the presence of flavonoids, glycosides, alkaloids, terpenoids, and steroids. Quantitative analysis for total 
phenolic content and total flavonoid content of the extract was 0.1±0.005 mg/ml GAE and 0.025±0.003 mg/ml QE respectively. Percent inhibition of 
α-amylase and α-glucosidase ascertained in presence of extract was 60.42±0.6 and 83.22±0.18 at 0.01 mg while 36.24±0.81 and 37.67±0.15 at 0.005 
mg of extracts for both enzymes respectively. Kinetics studies of α-glucosidase inhibition illustrated the non-competitive type of inhibition. TLC 
autography inhibition patterns were characterized by HR LC-MS. Characterized molecules on docking revealed (6RS)-22-hydroxy-23,24,25,26,27-
pentanor-vitamin-D3-6,19-sulfurdioxide-adduct, manoalide and 5β-cholestane-3α,7α,12α,24,25,26-hexol as the best docked molecules with lowest 
binding energies of-12.5,-11 and-10.2 kcal/mol for α-amylase and-14.2,-11 and-11.2 kcal/mol for α-glucosidase respectively. 
Conclusion: Results clearly suggested that (6RS)-22-hydroxy-23,24,25,26,27-pentanor-vitamin-D3-6,19-sulfurdioxide-adduct, manoalide and 5β-
cholestane-3α,7α,12α,24,25,26-hexol could be considered as lead molecules for the discovery of potent antidiabetic agents. 
Keywords: Helianthus annuus L., α-amylase, α-glucosidase, Kinetics study, Molecular docking 




Helianthus annuus L. (Sunflower) is an important oilseed crop of the 
world at the third position in production next to groundnut and 
soybean [1, 2]. The seeds are more commonly eaten as a healthy 
snack or included as part of a meal through the grill, pickle, hot 
sauce, bacon, ranch, nacho cheese, oil etc. Hence, the importance of 
Helianthus annuus L. as a source of edible oil as well as high-quality 
protein is continuously increasing [3].  
In addition to its nutritional benefits, sunflower seeds are also 
reported to have pharmacological activities which may be the result 
of the phytochemicals they possess. Thereby researchers are 
developing enthusiasm for chemical composition of Helianthus 
annuus L. which indeed found the presence of proteins, calcium, 
carbohydrates, fats and ash content [3]. Apart from these, 
phytochemicals like flavonoids, tannins, alkaloids, saponins, 
phytosterols, steroids and fixed oils were also reported in 
methanolic extracts of seeds of Helianthus annuus L. [4]. Caffeic acid, 
clorogenic acid and dicaffeoylquinic acid isolated from aqueous 
methanol extracts of sunflower are an addition to the list [5]. 
Phytochemicals extracted from Helianthus annuus L. seeds had been 
reported for a broad array of biological and pharmacological activities 
by several researchers [6]. Nevadensin, a bioflavonoid extracted from 
sunflower seeds revealed a wide range of significant biological 
activities like hypotensive, anti-tubercular, antimicrobial, anti-
inflammatory, anti-tumour and anti-cancer [7]. Aqueous extract of 
sunflower seed, when assessed in vivo on an ovalbumin-induced an 
anti-asthmatic model of mice, proposed its potential in reducing 
asthma [8]. Additionally, the ingestion of sunflower cotyledon extracts 
demonstrated the antioxidant capacity and thereby its potency to 
prevent cancer and other oxidative reaction related diseases [9]. The 
ethanolic extract of seeds was also claimed to be antihyperglycemic 
when administered in streptozotocin-nicotinamide-induced diabetic 
rats, showing a significant decrease in blood glucose level [10]. 
These potential health benefits invoked the need to investigate about 
different dietary phenolic constituents in Helianthus annuus L. seed 
extract having the capability of inhibiting α-amylase and α-glucosidase 
enzymes. This is because α-glucosidase and α-amylase inhibitors can 
retard the liberation of glucose from dietary complex carbohydrates 
and delay glucose absorption, resulting in reduced postprandial 
plasma glucose levels and suppress postprandial hyperglycaemia [11, 
12]. Consequently, α-glucosidase and α-amylase inhibitors are 
frequently administered to diabetics in many countries.  
Thus specifically, the aim of this study was to assess and 
characterize the phytochemical constituents in acetone extract of 
Helianthus annuus L. seeds having the potential of inhibiting α-
amylase and α-glucosidase demonstrated through in vitro as well as 
in silico strategies. 
MATERIALS AND METHODS 
Chemicals 
All solvents, along with the chemicals used in the qualitative and 
quantitative analysis of phytochemicals as well as α-amylase 
inhibition assay were purchased from HiMedia Pvt. Ltd. Mumbai. 
Acarbose, α-glucosidase and 4-nitrophenyl, α-D-glucopyranoside (ρ-
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NPG) were purchased from Sigma-Aldrich, India. Whereas, TLC Silica 
gel 60 F254 plates were purchased from Merck KGaA, Germany. 
Plant material 
Fresh, healthy seeds of Helianthus annuus L. were purchased from 
Yogesh Pharmacy, Nanded (Maharashtra), India. The seeds were 
rinsed with distilled water, dehydrated in an oven at 40 °C and 
crushed into a fine powder using mixer grinder. 20 gm of crushed 
powder was then used for extraction. 
Extraction 
Extraction of Helianthus annuus L. seed was carried out by hot 
percolation, using Soxhlet apparatus. Sequential extraction was done 
using solvents of increasing polarity. The progression used was 
petroleum ether, ethyl acetate, chloroform, acetone, ethanol, and 
water individually. Extraction of each solvent was continued for 6 to 
7 h and the temperature maintained was lower than the boiling 
points of individual solvents [13]. Depending upon our preliminary 
studies, acetone extract was used for further experimentation (data 
not shown). 
Qualitative tests for phytochemical analysis 
Acetone extract of Helianthus annuus L. was tested for presence of 
bioactive compounds like proteins, carbohydrates, phenols and 
tannins, flavonoids, saponins, glycosides, steroids, terpenoids, 
alkaloids, phlobatannins, fixed oils and fatty acids using standard 
methods of Sofowara, Trease and Harbone [14, 15]. 
Quantitative tests for phytochemical analysis 
Total phenolic content 
The amount of phenols in acetone extract was determined by Folin-
Ciocalteu reagent method with a few changes. 2.5 ml of 10 % folin-
ciocalteu reagent and 2 ml of 2 % solution of sodium carbonate was 
added to 1 ml of seed extract. The subsequent mixture was 
incubated for 15 min at room temperature. The absorbance of the 
sample was measured at 765 nm. Gallic acid was used as standard (1 
mg/ml). All the tests were performed in triplicates. The outcomes 
were determined from the standard curve and were expressed as 
gallic acid equivalent (GAE) (mg/g of the extracted compound) [16]. 
Total flavonoid content 
Aluminium chloride colourimetric method was used with a few 
alterations to determine flavonoid content. 1 ml of sample seed extract 
was mixed with 3 ml of methanol, 0.2 ml of 10 % aluminium chloride, 
0.2 ml of 1 M potassium acetate and 5.6 ml of distilled water and kept 
at room temperature for 30 min. The absorbance was measured at 420 
nm. Quercetin was used as standard (1 mg/ml). All the tests were 
performed in triplicates. Flavonoid contents were determined from 
the standard curve and were expressed as quercetin equivalent i.e. QE 
mg/g of extracted compound [16].  
TLC autography for the screening of α-amylase inhibitors 
Thin-layer chromatography was performed on the TLC silica gel 60 
F254 plates. Seed extract was spotted on the plate using a 
micropipette and allowed to dry. One dimensional TLC analysis was 
performed with our optimized solvent system of acetic acid: acetone: 
water (6:3.5:0.5) [17]. Spots were seen under Ultra-Violet light (UV 
light) at 254 nm and 366 nm. When separated bands were visible on 
TLC plate, it was then incubated in amylase solution for 30 min for the 
primary reaction between the enzyme and inhibitor. After incubation, 
the plate was taken out of the amylase solution and incubated in 1 % 
starch buffer of pH 6.9 for 10-20 min for enzyme-substrate reaction 
and later washed with Gram’s Iodine solution and observed [13]. 
α-amylase inhibition assay 
This assay was conducted using a standard method of Dinitro-
salicylic reagent [18] with a few alterations to investigate the 
inhibitory potential of α-amylase in presence of seed extract. In this 
assay, reaction mixture constituting 0.01 mg/ml and 0.005 mg/ml 
concentrations of seed extracts, 50 µl of phosphate buffer (0.02 M, 
pH 6.9) containing α-amylase solution (0.5 mg/ml) was incubated at 
25 °C for 30 min. At the end of incubation, 125 µl of 1 % starch buffer 
(0.02 M, pH 6.9) as substrate was added to each tube at 5 s intervals. 
The reaction mixtures were then again incubated at 25 °C for 10 
min. To terminate the reaction, 500 µl of dinitrosalicylic acid (DNSA) 
reagent was added and kept in boiling water bath for 5 min. 
Reaction tubes were allowed to cool to room temperature followed 
by addition of 2.5 ml distilled water to dilute the reaction mixture. 
The absorbance was measured at 540 nm and percent inhibition of 
α-amylase activity by given concentration of seed extract was 
calculated using the following formulae:  
 
α-glucosidase inhibition assay 
The inhibitory potency of seed extract against α-glucosidase activity 
was determined in 96-well micro-titer plate by earlier reported 
methods with slight modifications [19]. 5 μl of 0.01 mg and 0.005 mg 
concentration of seed extract was incubated individually with 5 μl of 
(0.25 U/ml) α-glucosidase enzyme for 15 min. The mixture was then 
added to 25 μl of phosphate buffer containing ρ-NPG (5 mmol, pH 
6.9) and final volume of the reaction mixture was made up to 180 μl 
by adding phosphate buffer (0.1 M, pH 6.9). The absorbance of the 
reaction was measured at 415 nm after 10 min of incubation [20]. 
Percent inhibition of α-glucosidase activity by given concentration of 
seed extract was calculated using the following formulae:  
 
α-glucosidase kinetic study 
Seed extract was evaluated for its effect on enzyme kinetics of 
inhibiting α-glucosidase activity using increasing concentrations of 
the substrate (ρ-NPG, 2 mmol-10 mmol) in absence or presence of 
inhibitors at different concentrations. The mode of inhibition (i.e. 
competitive, non-competitive, or uncompetitive) of seed extract was 
evaluated based on inhibitory effects on Km (dissociation constant) 
and Vmax (maximum reaction velocity) of the enzyme. This was 
determined using a Lineweaver–Burk plot analysis [21]. 
HR LC-MS analysis 
Separated bands showing positive outcomes in TLC autography 
were scratched out and processed for characterization of chemical 
constituents in them. This was done using HR LC-MS, Agilent 
Technologies, model: 1290 Infinity UHPLC System, 1260 infinity 
Nano HPLC with Chipcube, 6550 iFunnel Q-TOF. 
Molecular docking 
Preparation of protein structures 
Protein Data Bank (PDB) 3-Dimensional (3D) structures of α-
amylase (PDB Code: 3BC9) and α-glucosidase (PDB Code: 2QMJ) 
were obtained from PDB (http://www. rcsb. org). Using AutoDock 
Tools-1.5.6, [22, 23] those 3D structures were prepared as per 
recommended steps recommended in AutoDock tutorial [24]. These 
final refined structures were then used for molecular docking.  
Preparation of ligand molecules 
The structures of molecules identified from HR LC-MS analysis were 
downloaded from PubChem database (http://pubchem.ncbi. 
nlm.nih.gov) and ChemSpider [25] in Mol/SD format. Using Open Babel 
software [26], these structures were converted to PDB formats and 
filtered by Lipinski rule software (http://www.scfbio-iitd.res.in/ 
software/drugdesign/lipinski.jsp
Molecular docking analysis 
) [27]. In addition to these molecules, 
structures of standard inhibitors like acarbose, metformin, miglitol, and 
voglibose were also filtered by Lipinski rule software. Molecules obeying 
all the five rules of Lipinski were further processed as per recommended 
steps in AutoDock tutorial. 
Molecular docking or binding interaction of both α-amylase and α-
glucosidase enzymes with individual ligand molecules was 
performed using AutoDock Vina via PyRx software to obtain several 
possible conformations of the ligand at the binding site of the 
enzyme. After completion of docking, the binding energies 
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(kcal/mol) of each ligand with both the individual enzymes were 
obtained. The best confirmation of each ligand with a respective 
enzyme having lowest binding energy was chosen for further study.  
Interfering amino acids and their interactions involved 
Obtained conformations of the enzyme-ligand complex were 
analysed for specific amino acids involved in ligand binding sites of 
respective enzymes along with the type of interactions like Vander 
Waals, hydrogen bonding etc involved in the docking. This was 
performed using the Discovery Studio 4.1 Visualizer 
(http://accelrys.com/products/discovery-studio) [28]. Docked 
structures showing amino acid residues involved in the docking as 
well as the interactions between respective residues and ligand 
were image captured using image save option in Discovery Studio 
4.1 Visualizer. 
3D Ligand Site analysis 
For interpretation of amino acid residues involved in ligand binding 
site of both the enzymes, α-amylase and α-glucosidase enzymes 
were subjected independently to the 3DLigandSite server 
(http://www.sbg.bio.ic.ac.uk/3dligandsite
Prediction of active spectra for substances (PASS) Online) is a web 
server (http://www.pharmaexpert.ru/passonline/) [30] which 
facilitates the assessment of the general biological potential of an 
organic drug-like molecule like specific toxicities, mechanisms of 
action, and pharmacological effects that might be revealed by 
specific molecules. Here, SD files (.sdf) or MOL file (. mol) formats of 
ligands were subjected to the server. The assessment values were 
ranged from 0.000 to 1.000 and only those molecules were 
considered for further evaluation whose activity is Pa>Pi (Pa= 
Probability to be active; Pi= Probability to be inactive) [31]. 
) [29]. This server works 
on the basis of prediction of amino acid residues involved at binding 




Absorption, distribution, metabolism, excretion and toxicity 
(ADMET) properties of drug candidates or environmental chemicals 
are a fundamental part in drug discovery and environmental hazard 
assessment. For assessment of ADMET properties molecules 
showing positive results in PASS analysis were submitted to server 




Various properties such as blood-brain barrier, human intestinal 
absorption, AMES toxicity, carcinogenicity, and biodegradation for 
submitted molecules were calculated using this server.  
Qualitative tests for phytochemical analysis 
The phytochemical characteristics of acetone extract of Helianthus 
annuus L. seeds were tested and summarized in the table 1. Analysis 
revealed the presence of medically active compounds like steroids, 
flavonoids, glycosides, terpenoids and alkaloids in the extracts. 
 
Table 1: Qualitative tests for phytochemical analysis 
S. No. Tests Presence/Absence of phytoconstituents* 
1 Proteins Absent  
2 Carbohydrates Absent  
3 Phenols and Tannins Absent  
4 Flavonoids Present  
5 Saponins Absent  
6 Glycosides Present  
7 Steroids Present  
8 Terpenoids Present  
9 Alkaloids Present  
10 Fixed oil and Fatty acids Absent  
11 Phlobatannins Absent  
* indicates experiment performed in triplicate 
 
Quantitative tests for phytochemical analysis 
Total phenolic and flavonoid contents 
The total phenolic content of the extract was determined by Folin-
Ciocalteu reagent method and measured in terms of GAE showed 0.1 
mg/ml concentration whereas, the total flavonoid content measured 
in terms of QE showed 0.025 mg/ml concentration as depicted in the 
table 2. 
TLC autography for the screening of α-amylase inhibitors 
To screen-specific molecules acting as α-amylase inhibitors in the 
seed extract TLC autography was performed. Here separated bands 
demonstrating blue stains upon iodine staining on TLC plate were 
considered positive for TLC autography. Blue stained bands 
indicated presence of different mixtures of molecules or fractions 
responsible for α-amylase inhibition. This blue stain at that position 
was attributed to presence of starch which was not hydrolysed and 
thereby forming a starch-iodine complex. This was because of the 
inhibition of α-amylase activity by the compounds present in those 
fractions at that position. The TLC analysis revealed three bands in 
the extract when observed under UV light (at 366 nm). Blue spots 
were observed on two positions on the TLC plate as shown in fig. 1 
i.e., at positions one and three labelled from the sample loading end. 
The third band was showing higher colour intensity as compared to 
the first. Hence the third fraction was chosen for further analysis. 
 
Table 2: Quantitative tests for phytochemical analysis 
S. No. Tests Concentrations* 
1 Total Phenolic Content 0.1±0.005 mg/ml GAE 
2 Total Flavonoid Content 0.025±0.003 mg/ml QE 
*indicates mean±standard deviation values of an experiment performed in triplicate 
 
α-amylase inhibition assay 
This assay was performed to assess the inhibition of α-amylase by 
acetone extract of Helianthus annuus L. seed. Inhibition of α-
amylase by the extract was calculated and presented in table 3. As 
compared to the control reaction, the extract showed 60.42±0.6 % 
inhibition at 0.01 mg and 36.24±0.81 % inhibition at 0.005 mg 
concentration.
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Fig. 1: TLC autography. A. TLC plate after sample run in normal light; B. TLC plate after sample run in UV light; C. TLC plate after 
autography treatment 
 
Table 3: Enzyme Inhibition (percentage calculated at 0.01 and 0.005 mg concentrations) 
S. No. Enzyme Percent inhibition at 0.01 mg Percent inhibition at 0.005 mg 
1 α-amylase 60.42±0.6 36.24±0.81 
2 α-glucosidase 83.22±0.18 37.61±0.15 
*
 
α-glucosidase inhibition assay 
The activity of α-glucosidase in presence of seed extract was 
assessed to check the potency of extract for enzyme inhibition. Our 
findings reveal that 83.22±0.18 % inhibition by 0.01 mg and 
37.61±0.15 % inhibition by 0.005 mg of extract was observed as 
represented in table 3. 
indicates mean±standard deviation values of an experiment performed in triplicate 
α-glucosidase kinetics study 
As shown in fig. 2, all the data lines on the Line weaver–Burk plots 
intersected in the second quadrant, demonstrating that seed extract 
induced a non-competitive type of inhibition. The values of Vmax 
and Km with respect to the concentrations of extracts are 
represented in table 4. 
 
 
Fig. 2: Lineweaver-burk plot to determine the mode of inhibition of α-glucosidase activity by acetone extract of Helianthus annuus L. seeds 
 
Table 4: α-Glucosidase inhibition kinetics analysis 





-1 min-1 ml-1) x 10
Type of inhibition 
-7 
1 Control   5.86±0.05 5±0.05 - 
2 Acetone extract 2.5 0.005 6.664±0.05 5±0.05 Non-competitive inhibition 
5 0.01 7.222±0.05 5±0.05 
*indicates mean±standard deviation values of an experiment performed in triplicate 
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HR LC-MS analysis 
The third band fraction with higher intensity and showing positive 
results for TLC autography was scratched out and sent for HR LC-MS 
analysis. As the fraction was semi-purified, around 168 molecules 
were obtained in the analysis. Few of them were a repetition so they 
were counted once while structures of only few molecules were 
available on the online database so as a whole 22 molecules were 
left with their structures available. Some of the representatives are 
shown in fig. 3. 
 
 
Fig. 3: Representative HR LC-MS analysis MS Spectrum of compounds. A. 5β-Cholestane-3α,7α,12α,24,25,26-hexol; B. (6RS)-22-hydroxy-
23,24,25,26,27-pentanor-vitamin D3-6,19-sulfurdioxideadduct; C. Manoalide 
 
Molecular docking analysis 
All the 22 identified molecules filtered based on their potency to 
fulfil the Lipinski rules yielded only ten molecules as ligands for 
docking study. Miglitol was used as a standard inhibitor molecule for 
the comparison as it was alone capable of satisfying all the five rules 
of Lipinski in comparison to acarbose, metformin, and voglibose 
standards [33, 34]. The ligand molecules along with the standard 
miglitol were docked into the binding pockets of α-amylase and α-
glucosidase to find out their binding interactions.  
The docking results revealed different values of binding energies 
expressed in kcal/mol. All ten molecules showed lower binding 
energies with both the enzymes as compared to binding energies 
shown by miglitol (-6.1 and-5.9 kcal/mol for α-amylase and α-
glucosidase respectively). When representing the best three molecules 
of the rest, (6RS)-22-hydroxy-23,24,25,26,27-pentanor-vitamin-D3-
6,19-sulfurdioxide-adduct showed lowest binding energy followed by 
Manoalide and 5β-Cholestane-3α,7α,12α,24,25,26-hexol with scores 
of-12.5,-11 and-10.2 kcal/mol for α-amylase and-14.2,-11 and-11.2 
kcal/mol for α-glucosidase respectively as depicted in table 5. 
  
Table 5: Binding energies (kcal/mol) of compounds identified by HR LC-MS analysis and filtered by Lipinski rule with α-amylase and α-
glucosidase predicted through the virtual docking 
S. 
No. 
Ligands (Molecules) Binding energies with α-
Amylase 
Binding energies with α-
Glucosidase 




3 Manoalide -11 -11 
4 5β-Cholestane-3α,7α,12α,24,25,26-hexol -10.2 -11.2 
*Miglitol = a standard inhibitor. 
 
Interfering amino acids and their interactions involved 
The three best molecules obtained after docking analysis were then 
continued for prediction of different amino acid residues involved in 
the interactions between these protein-ligand complexes using 
Discovery Studio Visualizer 4.1.  
Different parameters were studied including, hydrogen bond 
interactions, π-π interactions, binding energy, root mean square 
deviation (RMSD) of active site residues and orientation of the 
docked compound within the active site [35]. Some of them are 
represented in table 6.  
Whereas, 2D images of three best-docked molecules along with a 
standard inhibitor miglitol with both α-amylase and α-glucosidase 
are shown in fig. 4 and fig. 6; while 3D images are shown in fig. 5 
and fig. 7 respectively. 
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Fig. 4: 2D images generated using discovery studio 4.1 Visualizer showing amino acid residues involved in interactions between α-
amylase and ligands. Here, the standard inhibitor and best three molecules with maximum binding energies are represented, where-A. 
(6RS)-22-hydroxy-23,24,25,26,27-pentanor-vitamin-D3-6,19-sulfurdioxide-adduct and α-amylase complex; B. 5β-Cholestane-
3α,7α,12α,24,25,26-hexol and α-amylase complex; C. Manoalide and α-amylase complex; D. Miglitol and α-amylase complex 
 
 
Fig. 5: 3D images generated using discovery studio 4.1 visualizer showing amino acid residues involved in interactions between α-
amylase and ligands. Here, the standard inhibitor and best three molecules with maximum binding energies are represented, where-A. 
(6RS)-22-hydroxy-23,24,25,26,27-pentanor-vitamin-D3-6,19-sulfurdioxide-adduct and α-amylase complex; B. 5β-Cholestane-
3α,7α,12α,24,25,26-hexol and α-amylase complex; C. Manoalide and α-amylase complex; D. Miglitol and α-amylase complex 
Kamble et al. 




Fig. 6: 2D images generated using Discovery Studio 4.1 Visualizer showing amino acid residues involved in interactions between α-
glucosidase and ligands. Here, the standard inhibitor and best three molecules with maximum binding energies are represented, where-
A. (6RS)-22-hydroxy-23,24,25,26,27-pentanor-vitamin-D3-6,19-sulfurdioxide-adduct and α-glucosidase complex; B. 5β-Cholestane-
3α,7α,12α,24,25,26-hexol and α-glucosidase complex; C. Manoalide and α-glucosidase complex; D. Miglitol and α-glucosidase complex 
 
 
Fig. 7: 3D images generated using Discovery Studio 4.1 Visualizer showing amino acid residues involved in interactions between α-
glucosidase and ligands. Here, the standard inhibitor and best three molecules with maximum binding energies are represented, where-
A. (6RS)-22-hydroxy-23,24,25,26,27-pentanor-vitamin-D3-6,19-sulfurdioxide-adduct and α-glucosidase complex; B. 5β-Cholestane-
3α,7α,12α,24,25,26-hexol and α-glucosidase complex; C. Manoalide and α-glucosidase complex; D. Miglitol and α-glucosidase complex 
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Table 6: Amino acid residues of α amylase and α-glucosidase showing different interactions in the company of ligands predicted using 
Discovery Studio Visualizer 4.1 
S. 
No. 
Molecules  α-Amylase amino acid residues showing different 
interactions 
α-Glucosidase amino acid residues showing 
different interactions 















1 Miglitol SER 326; ARG 282; 
TRP 331; TRP 359; 
ARG 318; PHE 363; 
GLY 319 
ALA 325; ILE 327; 
GLY 324; GLN 
317; ARG 361; 
ASP 368 
- LYS 131; LEU 130; 
LEU 143; PHE 82; 
GLU 78; GLY 128; GLY 








ASP 212; ARG 210; 
HIS 314; ASP 315; 
LEU 180; THR 178; 
GLN 78 
TRP 74; HIS 320 - LYS 563; ILE 557; SER 
560; GLU 564; ARG 
565; TYR 580; PRO 
566; LEU 556 
GLN 822 - 
3 Manoalide LYS 215; ASP 315; 
ARG 210; GLN 78; 
TYR 77 
TYR 166; GLU 
248 
ALA 213 ALA 356; GLN 822; 







GLU 255, TYR 166; 
LYS 215; ALA 213; 
ARG 210; ASP 315; 
HIS 320; TRP 73; 
TYR 77 
GLU 248; ASP 212 - ALA 553; TYR 580; 
LEU 556; ARG 565; 






3DLigand site analysis 
On submission of 3D structures of both the enzymes independently 
to the 3DLigandSite server, a list of amino acids from respective 
enzymes predicted for being involved in ligand binding was 
obtained. Similarity was observed on comparison of these findings 
with that of the amino acid predictions done using Discovery studio 
Visualizer 4.1 software.  
PASS analysis 
PASS analysis was used for calculating two probabilities of 
molecules i.e., probability of a molecule to be active or inactive (Pa 
and Pi) [31, 36]. Best three molecules based on docking reports were 
uploaded to PASS online server in the form of SD file (. sdf) or MOL 
file (. mol) formats. Additionally, a standard inhibitor miglitol was 
also submitted for PASS prediction. PASS analysis revealed that all 
the three molecules and standard miglitol have potential to act as α-
glucosidase inhibitors. Molecules with their Pi and Pa values are 
represented in table 7. Analysis also demonstrated the probability of 
(6RS)-22-hydroxy-23,24,25,26,27-pentanor-vitamin-D3-6,19-
sulfurdioxide-adduct and miglitol of having anti-diabetic activity. 
ADMET prediction 
ADMET and SAR properties of the three molecules and standard 
miglitol showing positive results in PASS analysis were predicted 
using server admetSAR. The obtained analysis reports are shown in 
table 8 and table 9. Overall analysis revealed the potential of all the 
three molecules to be considered as having drug-like properties 
based on ADMET and SAR criteria used for prediction. 
 
Table 7: PASS online prediction reports of molecules with Pa>Pi values along with their activities predicted at different values 
S. No. Molecules  Formula Pa value Pi value Activity 
1 Miglitol C8H17NO 0.486 5 0.007 α-Amylase inhibitor 
0.802 0.001 α-Glucosidase 
inhibitor 
0.658 0.008 Antidiabetic 
2 (6RS)-22-hydroxy-23,24,25,26,27-pentanor-vitamin-D3-6,19-
sulfurdioxide-adduct 
C22H34O4 0.252 S 0.113 Antidiabetic 
0.093 0.035 α-Glucosidase 
inhibitors 
3 Manoalide C25H36O 0.081 5 0.047 α-Glucosidase 
inhibitors 
4 5β-Cholestane-3α,7α,12α,24,25,26-hexol C27H48O 0.069 6 0.064 α-Glucosidase 
inhibitors 
 
Table 8: ADMET predicted profile for active compounds 






Blood brain barrier - + + + 
Human intestinal absorption + + + + 
Caco-2 permeability - - - - 
P-glycoprotein substrate S S S S 
P-glycoprotein inhibitor NI NI NI NI 
NI NI I NI 
Renal organic cation 
transporter 
NI NI NI NI 
Distribution 
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CYP450 2C9 S NS NS NS NS 
CYP450 2D6 S NS NS NS NS 
CYP450 3A4 S NS S S S 
CYP450 1A2 I NI NI NI NI 
CYP450 2C9 I NI NI NI NI 
CYP450 2D6 I NI NI NI NI 
CYP450 2C19 I NI NI NI NI 
CYP450 3A4 I NI NI NI NI 





WI WI WI WI 
NI I NI NI 
AMES toxicity NT NT NT NT 
Carcinogens toxicity NC NC NC NC 
Fish toxicity Low High High High 
Tetrahymena pyriformis 
toxicity 
Low High High High 
Honey bee toxicity Low High High High 
Biodegradation NB NB NB NB 
Acute oral toxicity III III I III 
Carcinogenicity (Three-class) No No No No 
+: Positive; -: Negative; S: Substrate; NS: Non-Substrate; I: Inhibitor; WI: Weak Inhibitor NI: Non-Inhibitor; NT: Non-Toxic; NC: Non-Carcinogenic; 
NB: Not ready biodegradable; No: Not Required. 
 
Table 9: ADMET predicted profile regression 






Aq. Solubility (Log S) -0.22 -3.59 -3.75 -3.1 
Caco-2 permeability (Log 
P app, cm/s) 





Rat (LD 50, mol/kg) 1.74 2.42 4.26 2.68 
Fish (pLC50, mg/l) 2.83 1.3 0.7 1.64 
Tetrahymena pyriformis 
(pIGC50, ug/l) 
-0.52 0.59 1.06 0.79 
 
DISCUSSION 
Helianthus annuus L. is one of the herbs with therapeutic esteem and 
is utilized worldwide as nourishment and medication [3, 6]. Because 
of its daily consumption in human life, it can also be considered as a 
functional food. Its phytochemical constituents contribute in number 
of traditional uses for human welfare. So, this study was planned by 
us with a focus on analysis of phytochemicals present in the 
Helianthus annuus L. seed extracts followed by their 
characterization. Based on our preliminary studies using sequential 
extraction of sunflower seeds (data not shown), acetone extract was 
focused in this study. To determine the phytochemicals in acetone 
extract of seed, both qualitative and quantitative analysis was done. 
Our qualitative analysis revealed the presence of flavonoids, 
glycosides, steroids, terpenoids, and alkaloids. While quantitative 
analysis data showed that the phenolic content was 0.1 mg/ml GAE 
while 0.025 mg/ml QE was the total flavonoid content. 
Helianthus annuus L. seed acetone extract was semi-purified and 
screened for the presence of α-amylase and α-glucosidase inhibitors. 
From this screening, it was found that concentration of 0.01 mg 
semi-purified seed extract could show an inhibition of 60.42±0.6 and 
83.22±0.18 % of α-amylase and α-glucosidase enzyme activity 
respectively. Moreover, when the concentration of semi-purified 
Helianthus annuus L. seed extract was reduced to half i.e. 0.005 mg, 
the extract showed 36.24±0.81 and 37.61±0.15 % inhibition of α-
amylase and α-glucosidase enzyme activity respectively. Enzyme 
inhibition kinetics in presence and absence of inhibitor was further 
studied only for α-glucosidase activity wherein the mode of 
inhibition was predicted, and it was found to be the non-competitive 
type of inhibition.  
Different extracts of Helianthus annuus L. seed inhibiting α-amylase 
and α-glucosidase have been reported earlier but the specific 
molecules in those respective extracts with potency to inhibit α-
amylase and α-glucosidase were not yet reported [6, 10]. In the 
present study, using our devised methodology of TLC autography, 
we could screen crude acetone extract of Helianthus annuus L. 
showing inhibitory activity, followed by semi-purification of fraction 
scratched from TLC plate and finally characterization of bioactive 
phytochemicals in the semi-purified fraction by HR LC-MS. 
HR LC-MS analysis uncovered the presence of various molecules 
which were hypothesized to have enzyme inhibition potential. 
Literature survey confirmed our hypothesis that few of molecules 
characterized in our extracts like madecassic acid, linoleamide, 
cephaeline, and phenylethylamine were reported for antidiabetic 
properties [37-40]. However, when these molecules were filtered for 
Lipinski rule, all of them could not pass the rule and hence were not 
a suitable lead. So, it was necessary to filter 168 HR LC-MS 
characterized molecules via Lipinski rule which thereby yielded ten 
molecules fulfilling the criteria.  
These ten molecules along with a standard inhibitor miglitol were 
successfully docked in silico with both α-amylase and α-glucosidase 
enzymes to find the enzyme-ligand interactions. Out of ten, (6RS)-
22-hydroxy-23,24,25,26,27-pentanor-vitamin-D3-6,19-sulfur 
Kamble et al. 
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dioxide-adduct, Manoalide and 5β-Cholestane-3α,7α,12α,24,25,26-
hexol demonstrated lowest binding energies therefore could be 
considered as potential inhibitors for α-amylase as well as α-
glucosidase. Further, comparing the investigation performed using 
Discovery Studio 4.1 Visualizer and 3DLigandSite server; we found 
that similar amino acid residues were involved in the ligand binding 
site of both enzymes. Use of in silico molecular docking thus proves 
to be an effective way for screening a large number of lead molecules 
interacting with the enzyme as a target thereby reducing time and 
expenses for in vivo studies.  
Further, three best molecules from molecular docking analysis were 
assessed for PASS analysis to predict their active spectra. This 
analysis revealed that all three molecules have the potential of α-
glucosidase inhibitory activity. Thus, these three molecules were 
then considered as lead and tested for ADMET and SAR prediction.  
It is well known that ADMET properties of chemicals or drug 
candidates play an important role in drug discovery as well as an 
environmental hazard assessment [41, 42]. Using admetSAR server, 
absorption predictions of the molecules for various models like a 
blood-brain barrier (BBB), human intestinal absorption (HIA), Caco-2 
permeability, P-glycoprotein substrate, P-glycoprotein inhibitors, and 
renal organic cation transporter were checked. In case of metabolism, 
predictions for drug metabolism by cytochrome P450 (CYP) group of 
isozymes were checked; and in case of toxicity prediction, all the 
toxicity models like fish toxicity, AMES toxicity, Tetrahymena 
pyriformis toxicity, honey bee toxicity, biodegradation, acute oral 
toxicity, carcinogens toxicity, etc were checked. Obtained regression 
values revealed that a portion of the models was predicted with potent 
risks and thereby indicated unfavourable results. However, they have 
very low predicted probability values and in comparison, with 
probability values obtained from standard drug miglitol all the three 
molecules from our study could show drug-like properties or strongly 
support the capability of molecules to act as a drug [43, 44]. So, our 
studies put forward this as the first report on isolation and 
characterization of acetone extract of Helianthus annuus L. seed having 
α-amylase and α-glucosidase inhibitory or antidiabetic potential. 
CONCLUSION 
Helianthus annuus L. is the hub of medicinal values and easily 
accessible for human utilization. So, our focus was to estimate the 
phytochemicals present in the acetone extract of Helianthus annuus 
L. seeds and to screen for α-amylase and α-glucosidase inhibitors in 
vitro as well as in silico. Considering the side effects of synthetic 
inhibitors available in the market, and to support a more beneficial 
way of life for individuals, this study was designed. Screening of 
phytoconstituents as α-amylase and α-glucosidase inhibitors with 
low or no side effects was the primary aim of this investigation. Also, 
here the outcome of the investigation revealed potency of seed 
extract towards inhibition of α-amylase as well as α-glucosidase 
with minimum 0.005 mg concentration. Our in silico study reveals 
that ten molecules inhibit both α-amylase and α-glucosidase better 
than the standard miglitol and also follow the Lipinski rule. 
Furthermore, the best three were (6RS)-22-hydroxy-23,24,25,26,27-
pentanor-vitamin-D3-6,19-sulfur dioxide-adduct (-12.5 and-14.2 
kcal/mol), Manoalide (-11 and-11 kcal/mol) and 5β-Cholestane-
3α,7α,12α,24,25,26-hexol (-10.2 and-11.2 kcal/mol) respectively. 
Moreover, based on their PASS analysis and ADMET predictions 
these three molecules could be considered as lead molecules for 
antidiabetic drugs. However, the further detail in vivo investigation 
must be carried out before these molecules could be used as potent 
antidiabetic agents. (We have claimed these results for a patent with 
Indian Patent Authority, Ref. No./Application No.-201621036607). 
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